Company conducts sale of 4 million common shares at $5.00 per share
By Devika Patel
Knoxville, Tenn., Jan. 31 - Regado Biosciences, Inc. said it has arranged a $20 million private placement of stock. Cowen and Co. is the lead agent and BMO Capital Markets is the co-placement agent.
The company will sell 4 million common shares at $5.00 per share. The price per share is a 20% discount to the Jan. 30 closing share price of $6.25.
Settlement is expected Feb. 5.
Proceeds will be used for general corporate and working capital purposes.
The biopharmaceutical company is based in Basking Ridge, N.J.
| Issuer: | Regado Biosciences, Inc.
|
| Issue: | Common stock
|
| Amount: | $20 million
|
| Shares: | 4 million
|
| Price: | $5.00
|
| Warrants: | No
|
| Agents: | Cowen and Co. (lead) and BMO Capital Markets (co-placement agent)
|
| Pricing date: | Jan. 31
|
| Settlement date: | Feb. 5
|
| Stock symbol: | Nasdaq: RGDO
|
| Stock price: | $6.25 at close Jan. 30
|
| Market capitalization: | $132.97 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
